Toublet, F.-X.; Lecoutey, C.; Lalut, J.; Hatat, B.; Davis, A.; Since, M.; Corvaisier, S.; Freret, T.; Sopkova de Oliveira Santos, J.; Claeysen, S.;
et al. Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules 2019, 24, 2786.
https://doi.org/10.3390/molecules24152786
AMA Style
Toublet F-X, Lecoutey C, Lalut J, Hatat B, Davis A, Since M, Corvaisier S, Freret T, Sopkova de Oliveira Santos J, Claeysen S,
et al. Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules. 2019; 24(15):2786.
https://doi.org/10.3390/molecules24152786
Chicago/Turabian Style
Toublet, François-Xavier, Cédric Lecoutey, Julien Lalut, Bérénice Hatat, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Freret, Jana Sopkova de Oliveira Santos, Sylvie Claeysen,
and et al. 2019. "Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease" Molecules 24, no. 15: 2786.
https://doi.org/10.3390/molecules24152786
APA Style
Toublet, F.-X., Lecoutey, C., Lalut, J., Hatat, B., Davis, A., Since, M., Corvaisier, S., Freret, T., Sopkova de Oliveira Santos, J., Claeysen, S., Boulouard, M., Dallemagne, P., & Rochais, C.
(2019). Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules, 24(15), 2786.
https://doi.org/10.3390/molecules24152786
